Oculis Holding AG
OCSAW7.260USD
-0.980-12.10%
Market hours （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Oculis Holding AG Company
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Company Info
Ticker SymbolOCSAW
Company nameOculis Holding AG
IPO dateMar 03, 2023
CEODr. Riad Sherif, M.D.
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
AddressBahnhofstrasse 20
CityZUG
Stock exchangeNASDAQ Global Market Consolidated
CountrySwitzerland
Postal code6300
Phone41417113960
Websitehttps://oculis.com/
Ticker SymbolOCSAW
IPO dateMar 03, 2023
CEODr. Riad Sherif, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dhr. Martijn Kleijwegt ,
Dhr. Martijn Kleijwegt ,
Independent Director
Independent Director
--
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Joanne Chang, M.D., Ph.D.
Dr. Joanne Chang, M.D., Ph.D.
Head - Medical Affairs
Head - Medical Affairs
--
--
Dr. Pravin U. Dugel, M.D.
Dr. Pravin U. Dugel, M.D.
Independent Director
Independent Director
--
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
--
--
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bastian Dehmel, M.D.
Dr. Bastian Dehmel, M.D.
Head - Development
Head - Development
--
--
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
--
--
Dr. Sharon Klier, M.D.
Dr. Sharon Klier, M.D.
Chief Development Officer
Chief Development Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dhr. Martijn Kleijwegt ,
Dhr. Martijn Kleijwegt ,
Independent Director
Independent Director
--
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Joanne Chang, M.D., Ph.D.
Dr. Joanne Chang, M.D., Ph.D.
Head - Medical Affairs
Head - Medical Affairs
--
--
Dr. Pravin U. Dugel, M.D.
Dr. Pravin U. Dugel, M.D.
Independent Director
Independent Director
--
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Strategy Officer
Chief Strategy Officer
--
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
No Data
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
